Morrow S - Search Results

1

Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index.

Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, Sampalis J, Conner-Spady B. Maksymowych WP, et al. Among authors: morrow s. Ann Rheum Dis. 2009 Jun;68(6):948-53. doi: 10.1136/ard.2007.084244. Epub 2008 Jun 4. Ann Rheum Dis. 2009. PMID: 18524792 Clinical Trial.

2

The validity and reliability of the neurogenic bladder symptom score.

Welk B, Morrow S, Madarasz W, Baverstock R, Macnab J, Sequeira K. Welk B, et al. Among authors: morrow s. J Urol. 2014 Aug;192(2):452-7. doi: 10.1016/j.juro.2014.01.027. Epub 2014 Feb 8. J Urol. 2014. PMID: 24518764

3

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.

Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA; Canadian MS Working Group. Freedman MS, et al. Among authors: morrow sa. Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6. Can J Neurol Sci. 2020. PMID: 32654681 Review.

4

The conceptualization and development of a patient-reported neurogenic bladder symptom score.

Welk B, Morrow SA, Madarasz W, Potter P, Sequeira K. Welk B, et al. Res Rep Urol. 2013 Oct 10;5:129-37. doi: 10.2147/RRU.S51020. eCollection 2013. Res Rep Urol. 2013. PMID: 24400244 Free PMC article.

5

Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism.

Welk B, McArthur E, Morrow SA, MacDonald P, Hayward J, Leung A, Lum A. Welk B, et al. JAMA. 2016 Jul 5;316(1):96-8. doi: 10.1001/jama.2016.8096. JAMA. 2016. PMID: 27380348 No abstract available.

6

The risk of dementia with the use of 5 alpha reductase inhibitors.

Welk B, McArthur E, Ordon M, Morrow SA, Hayward J, Dixon S. Welk B, et al. Among authors: morrow sa. J Neurol Sci. 2017 Aug 15;379:109-111. doi: 10.1016/j.jns.2017.05.064. Epub 2017 May 31. J Neurol Sci. 2017. PMID: 28716218

7

Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with multiple sclerosis.

Morrow SA, Rosehart H, Sener A, Welk B. Morrow SA, et al. J Neurol Sci. 2018 Feb 15;385:39-44. doi: 10.1016/j.jns.2017.11.028. Epub 2017 Nov 22. J Neurol Sci. 2018. PMID: 29406911

8

Concussion in adolescence and the risk of multiple sclerosis: A retrospective cohort study.

Povolo CA, Reid JN, Shariff SZ, Welk B, Morrow SA. Povolo CA, et al. Mult Scler. 2021 Feb;27(2):180-187. doi: 10.1177/1352458520908037. Epub 2020 Feb 24. Mult Scler. 2021. PMID: 32091315

9

High dose oral steroids commonly used to treat relapses in Canadian MS clinics.

Morrow SA, Metz LM, Kremenchutzky M. Morrow SA, et al. Can J Neurol Sci. 2009 Mar;36(2):213-5. doi: 10.1017/s0317167100120293. Can J Neurol Sci. 2009. PMID: 19378717

10

The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.

Ploughman M, Beaulieu S, Harris C, Hogan S, Manning OJ, Alderdice PW, Fisk JD, Sadovnick AD, O'Connor P, Morrow SA, Metz LM, Smyth P, Mayo N, Marrie RA, Knox KB, Stefanelli M, Godwin M. Ploughman M, et al. Among authors: morrow sa. BMJ Open. 2014 Jul 10;4(7):e005718. doi: 10.1136/bmjopen-2014-005718. BMJ Open. 2014. PMID: 25011993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters